ONCOLYZE Trademark

Trademark Overview

On Wednesday, March 14, 2018, a trademark application was filed for ONCOLYZE with the United States Patent and Trademark Office. The USPTO has given the ONCOLYZE trademark a serial number of 87834118. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by ONCOLYZE, INC.. The ONCOLYZE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical and pharmaceutical research services; pharmaceutical research and development
oncolyze

General Information

Serial Number87834118
Word MarkONCOLYZE
Filing DateWednesday, March 14, 2018
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6434837
Registration DateTuesday, July 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and Servicesmedical and pharmaceutical research services; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 21, 2018
Primary Code042
First Use Anywhere DateFriday, July 29, 2011
First Use In Commerce DateFriday, July 29, 2011

Trademark Owner History

Party NameONCOLYZE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameONCOLYZE, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameONCOLYZE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Friday, June 25, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 24, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 16, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, August 14, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 13, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 13, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, August 13, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 13, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, August 13, 2019SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, June 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019SU - NON-FINAL ACTION - WRITTEN
Thursday, May 9, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, May 3, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, April 30, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 29, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 10, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 21, 2019USE AMENDMENT FILED
Saturday, April 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 21, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 25, 2018ASSIGNED TO EXAMINER
Wednesday, March 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 17, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncolyze pharmaceutical research development services medical